# Measurement of HTL0016878 in Cerebrospinal Fluid

> **NCT04849286** · PHASE1 · COMPLETED · sponsor: **Nxera Pharma UK Limited** · enrollment: 16 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** HTL0016878

## Key facts

- **NCT ID:** NCT04849286
- **Lead sponsor:** Nxera Pharma UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-26
- **Primary completion:** 2018-12-07
- **Final completion:** 2018-12-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04849286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04849286, "Measurement of HTL0016878 in Cerebrospinal Fluid". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04849286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*